Translational Research

Conference Coverage

CDK8 inhibitor shows activity against AML

DUBROVNIK, CROATIA – SEL120 looks active against acute myeloid leukemia in preclinical work, but experts aren’t sure why.

From the Journals

Eltrombopag irons out kinks in hematopoiesis

The thrombopoietin-receptor agonist’s iron-chelating action stimulates hematopoietic stem cell activity, independent of the thrombopoietin...

From the Editor

The enemy of good

By setting narrow limits on study eligibility, we risk treatment rationing through regulatory restriction.